INDV
Indivior Pharmaceuticals Inc
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$34.94
+0.32%Forward multiples
Based on analyst estimates
- P/E forward
- 7.73x
- P/E 2026E
- 8.30x
- P/E 2027E
- 7.58x
- P/E 2028E
- 7.24x
- P/S forward
- 3.07x
Trailing multiples
Trailing twelve months
- P/E TTM
- 12.30x
- PEG TTM
- 0.21x
- Price / book
- -19.83x
- Price / sales
- 3.10x
- Price / cash flow
- -103.10x
Enterprise value
- Enterprise value
- $4.4B
- EV / sales
- 3.31x
- EV / EBITDA
- 10.21x
- EV / EBIT
- 8.52x
- Market cap
- $4.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026